We are analyzing https://link.springer.com/article/10.1007/s10549-009-0674-9.

Title:
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients | Breast Cancer Research and Treatment
Description:
Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots, which can be used to assess the relevance of the expression levels of various genes on the clinical outcome both in untreated and treated breast cancer patients. A background database was established using gene expression data and survival information of 1,809 patients downloaded from GEO (Affymetrix HGU133A and HGU133+2 microarrays). The median relapse free survival is 6.43 years, 968/1,231 patients are estrogen-receptor (ER) positive, and 190/1,369 are lymph-node positive. After quality control and normalization only probes present on both Affymetrix platforms were retained (n = 22,277). In order to analyze the prognostic value of a particular gene, the cohorts are divided into two groups according to the median (or upper/lower quartile) expression of the gene. The two groups can be compared in terms of relapse free survival, overall survival, and distant metastasis free survival. A survival curve is displayed, and the hazard ratio with 95% confidence intervals and logrank P value are calculated and displayed. Additionally, three subgroups of patients can be assessed: systematically untreated patients, endocrine-treated ER positive patients, and patients with a distribution of clinical characteristics representative of those seen in general clinical practice in the US. Web address: www.kmplot.com . We used this integrative data analysis tool to confirm the prognostic power of the proliferation-related genes TOP2A and TOP2B, MKI67, CCND2, CCND3, CCNDE2, as well as CDKN1A, and TK2. We also validated the capability of microarrays to determine estrogen receptor status in 1,231 patients. The tool is highly valuable for the preliminary assessment of biomarkers, especially for research groups with limited bioinformatic resources.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

breast, cancer, article, google, scholar, pubmed, cas, gene, expression, patients, survival, prognostic, res, analysis, data, research, prognosis, clinical, oncol, genes, microarray, estrogen, clin, status, profiling, privacy, cookies, content, tool, györffy, receptor, access, information, publish, search, lanczky, eklund, zoltan, szallasi, metastasis, markers, adjuvant, early, nodenegative, profiles, treat, bmc, molecular, desmedt, grade,

Topics {✒️}

formalin-fixed paraffin-embedded tissue month download article/chapter gene-expression profiling study gene-expression pro-files node-negative breast cancer gene expression profiling proliferation-related genes top2a breast cancer prognosis early breast cancer survival analysis study relapse free survival relapse-free survival gene expression measurements breast cancer patients gene expression data 76-gene prognostic signature lymph-node positive estrogen receptor analysis primary breast tumors full article pdf privacy choices/manage cookies biological sequence analysis kiaa0101 gene revealed spitznagel el jr draw survival plots estrogen-positive tumors predict distant metastasis author information authors tumor markers population-based validation estrogen receptor discordance article györffy meta-analysis gene expression oestrogen-receptor status hormone receptor status key prognostic impact balazs györffy breast cancer related subjects prognostic model adjuvant population-based cohorts molecular profiling general clinical practice european economic area upper/lower quartile limited bioinformatic resources scarff-bloom-richardson project shows inter fine-needle aspirations

Questions {❓}

Colozza M, Azambuja E, Cardoso F et al (2005) Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
         description:Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots, which can be used to assess the relevance of the expression levels of various genes on the clinical outcome both in untreated and treated breast cancer patients. A background database was established using gene expression data and survival information of 1,809 patients downloaded from GEO (Affymetrix HGU133A and HGU133+2 microarrays). The median relapse free survival is 6.43 years, 968/1,231 patients are estrogen-receptor (ER) positive, and 190/1,369 are lymph-node positive. After quality control and normalization only probes present on both Affymetrix platforms were retained (n = 22,277). In order to analyze the prognostic value of a particular gene, the cohorts are divided into two groups according to the median (or upper/lower quartile) expression of the gene. The two groups can be compared in terms of relapse free survival, overall survival, and distant metastasis free survival. A survival curve is displayed, and the hazard ratio with 95% confidence intervals and logrank P value are calculated and displayed. Additionally, three subgroups of patients can be assessed: systematically untreated patients, endocrine-treated ER positive patients, and patients with a distribution of clinical characteristics representative of those seen in general clinical practice in the US. Web address: www.kmplot.com . We used this integrative data analysis tool to confirm the prognostic power of the proliferation-related genes TOP2A and TOP2B, MKI67, CCND2, CCND3, CCNDE2, as well as CDKN1A, and TK2. We also validated the capability of microarrays to determine estrogen receptor status in 1,231 patients. The tool is highly valuable for the preliminary assessment of biomarkers, especially for research groups with limited bioinformatic resources.
         datePublished:2009-12-18T00:00:00Z
         dateModified:2009-12-18T00:00:00Z
         pageStart:725
         pageEnd:731
         sameAs:https://doi.org/10.1007/s10549-009-0674-9
         keywords:
            Survival analysis
            Breast cancer
            Prognosis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0674-9/MediaObjects/10549_2009_674_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0674-9/MediaObjects/10549_2009_674_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0674-9/MediaObjects/10549_2009_674_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:123
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Balazs Györffy
               affiliation:
                     name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
                     address:
                        name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Andras Lanczky
               affiliation:
                     name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
                     address:
                        name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
                        type:PostalAddress
                     type:Organization
                     name:Pazmany Peter University
                     address:
                        name:Pazmany Peter University, Budapest, Hungary
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aron C. Eklund
               affiliation:
                     name:Technical University of Denmark
                     address:
                        name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carsten Denkert
               affiliation:
                     name:Charité Universitaetsmedizin
                     address:
                        name:Charité Universitaetsmedizin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jan Budczies
               affiliation:
                     name:Charité Universitaetsmedizin
                     address:
                        name:Charité Universitaetsmedizin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qiyuan Li
               affiliation:
                     name:Technical University of Denmark
                     address:
                        name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zoltan Szallasi
               affiliation:
                     name:Technical University of Denmark
                     address:
                        name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                        type:PostalAddress
                     type:Organization
                     name:Harvard Medical School
                     address:
                        name:Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
      description:Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots, which can be used to assess the relevance of the expression levels of various genes on the clinical outcome both in untreated and treated breast cancer patients. A background database was established using gene expression data and survival information of 1,809 patients downloaded from GEO (Affymetrix HGU133A and HGU133+2 microarrays). The median relapse free survival is 6.43 years, 968/1,231 patients are estrogen-receptor (ER) positive, and 190/1,369 are lymph-node positive. After quality control and normalization only probes present on both Affymetrix platforms were retained (n = 22,277). In order to analyze the prognostic value of a particular gene, the cohorts are divided into two groups according to the median (or upper/lower quartile) expression of the gene. The two groups can be compared in terms of relapse free survival, overall survival, and distant metastasis free survival. A survival curve is displayed, and the hazard ratio with 95% confidence intervals and logrank P value are calculated and displayed. Additionally, three subgroups of patients can be assessed: systematically untreated patients, endocrine-treated ER positive patients, and patients with a distribution of clinical characteristics representative of those seen in general clinical practice in the US. Web address: www.kmplot.com . We used this integrative data analysis tool to confirm the prognostic power of the proliferation-related genes TOP2A and TOP2B, MKI67, CCND2, CCND3, CCNDE2, as well as CDKN1A, and TK2. We also validated the capability of microarrays to determine estrogen receptor status in 1,231 patients. The tool is highly valuable for the preliminary assessment of biomarkers, especially for research groups with limited bioinformatic resources.
      datePublished:2009-12-18T00:00:00Z
      dateModified:2009-12-18T00:00:00Z
      pageStart:725
      pageEnd:731
      sameAs:https://doi.org/10.1007/s10549-009-0674-9
      keywords:
         Survival analysis
         Breast cancer
         Prognosis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0674-9/MediaObjects/10549_2009_674_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0674-9/MediaObjects/10549_2009_674_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0674-9/MediaObjects/10549_2009_674_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:123
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Balazs Györffy
            affiliation:
                  name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
                  address:
                     name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Andras Lanczky
            affiliation:
                  name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
                  address:
                     name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
                     type:PostalAddress
                  type:Organization
                  name:Pazmany Peter University
                  address:
                     name:Pazmany Peter University, Budapest, Hungary
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aron C. Eklund
            affiliation:
                  name:Technical University of Denmark
                  address:
                     name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carsten Denkert
            affiliation:
                  name:Charité Universitaetsmedizin
                  address:
                     name:Charité Universitaetsmedizin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jan Budczies
            affiliation:
                  name:Charité Universitaetsmedizin
                  address:
                     name:Charité Universitaetsmedizin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qiyuan Li
            affiliation:
                  name:Technical University of Denmark
                  address:
                     name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zoltan Szallasi
            affiliation:
                  name:Technical University of Denmark
                  address:
                     name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
                     type:PostalAddress
                  type:Organization
                  name:Harvard Medical School
                  address:
                     name:Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:123
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
      address:
         name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
         type:PostalAddress
      name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
      address:
         name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
         type:PostalAddress
      name:Pazmany Peter University
      address:
         name:Pazmany Peter University, Budapest, Hungary
         type:PostalAddress
      name:Technical University of Denmark
      address:
         name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
         type:PostalAddress
      name:Charité Universitaetsmedizin
      address:
         name:Charité Universitaetsmedizin, Berlin, Germany
         type:PostalAddress
      name:Charité Universitaetsmedizin
      address:
         name:Charité Universitaetsmedizin, Berlin, Germany
         type:PostalAddress
      name:Technical University of Denmark
      address:
         name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
         type:PostalAddress
      name:Technical University of Denmark
      address:
         name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Balazs Györffy
      affiliation:
            name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
            address:
               name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Andras Lanczky
      affiliation:
            name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University
            address:
               name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
               type:PostalAddress
            type:Organization
            name:Pazmany Peter University
            address:
               name:Pazmany Peter University, Budapest, Hungary
               type:PostalAddress
            type:Organization
      name:Aron C. Eklund
      affiliation:
            name:Technical University of Denmark
            address:
               name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
               type:PostalAddress
            type:Organization
      name:Carsten Denkert
      affiliation:
            name:Charité Universitaetsmedizin
            address:
               name:Charité Universitaetsmedizin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Jan Budczies
      affiliation:
            name:Charité Universitaetsmedizin
            address:
               name:Charité Universitaetsmedizin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Qiyuan Li
      affiliation:
            name:Technical University of Denmark
            address:
               name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
               type:PostalAddress
            type:Organization
      name:Zoltan Szallasi
      affiliation:
            name:Technical University of Denmark
            address:
               name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
               type:PostalAddress
            type:Organization
            name:Harvard Medical School
            address:
               name:Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
      name:Joint Research Laboratory of the Hungarian Academy of Sciences and the Semmelweis University, Budapest, Hungary
      name:Pazmany Peter University, Budapest, Hungary
      name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
      name:Charité Universitaetsmedizin, Berlin, Germany
      name:Charité Universitaetsmedizin, Berlin, Germany
      name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
      name:Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
      name:Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(126)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Foundation
Prism.js

CDN Services {📦}

Crossref

3.64s.

LINK . SPRINGER . COM {}